Compounds of formula (I) which are useful in ameliorating conditions characterized by unwanted sodium and/or calcium channel actrvrh, particularly Na
v
1.7, Na
v
1.8, or Ca
v
3.2 channel activity are disclosed. More specifically, compounds for use in the treatment of conditions such as epilepsy, cancer, pain, migraine, Parkinson's disease, depression, schizophrenia, psychosis, and tinnitus are disclosed.
公式(I)的化合物被用于改善由不需要的
钠和/或
钙通道活性引起的病症,特别是Nav1.7、Nav1.8或Cav3.2通道活性。更具体地,公开了用于治疗癫痫、癌症、疼痛、偏头痛、帕
金森病、抑郁症、精神分裂症和耳鸣等疾病的化合物。